Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > A lot of Red

<< Previous

Bullboard Posts

Next >>

Comment by ForexWhaleon Sep 11, 2018 12:22pm

117 Views

Post# 28597856

RE:RE:A lot of Red

I think in every sector depends on company and products/direction they have. No magic formula or one sector that will make you rich. Do the analysis and then find the winners. ICO has solid numbers for a drug worth billions from the Phase 1 study. That is why i am sure it will be best for my investment.

Good luck in where ever you ivnest.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale